Wellcome and Nature Launch Award to Highlight Mental Health Research
A new award from Wellcome and Nature seeks to increase visibility for mental-health research. The initiative comes as global funding for the field has declined in recent years.
thehkhub.comMore than one billion people worldwide live with a mental-health condition, according to the World Health Organization. Anxiety and depression affect close to 700 million people, and approximately 700,000 individuals die by suicide each year. Governments allocate a median of 2% of health budgets to mental-health services.
Funding for mental-health research fell to 2014 levels by 2023 after earlier growth between 2014 and 2020.
Wellcome and Nature have created a new award to raise the profile of mental-health research. The organizations state that outcomes from such studies do not always reach people who could benefit. The award will recognize work that improves understanding or treatment of mental-health conditions.
Organizers expect the prize to encourage greater attention to the field among researchers and funders. Shortages of trained mental-health professionals remain widespread. Low- and middle-income countries allocate even smaller shares of health spending to these services than the global median.
Key Facts
Story Timeline
3 events- 2014-2020
Global funding for mental-health research grew steadily.
1 source@Nature - 2023
Mental-health research funding returned to 2014 levels in real terms.
1 source@Nature - 2026
Wellcome and Nature announced a new award for mental-health research.
1 source@Nature
Potential Impact
- 01
The award may encourage additional researchers to focus on mental-health topics.
- 02
Increased visibility could prompt some funders to review mental-health grant allocations.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…